A single and multiple ascending dose study to investigate the safety, tolerability, and pharmacokinetics of AZD8965 in healthy participants (including Japanese and Chinese participants) and an open-label cohort to assess the effect of food on the pharmacokinetics of AZD8965 in healthy participants

Trial Identifier: D6960C00001
Sponsor: AstraZeneca
Start Date: August 2024
Primary Completion Date: November 2025
Study Completion Date: November 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, CA Glendale, CA, US, 91206